Log in

MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. NASDAQ · United States

MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) news

Latest MARAVAI LIFESCIENCES HOLDINGS, INC. news

We have not published a story on MARAVAI LIFESCIENCES HOLDINGS, INC. yet. When there is news, it will appear here.

MARAVAI LIFESCIENCES HOLDINGS, INC. annual financials

LineFY2025FY2024
Revenue$185.7 million$259.2 million
Research and development$17.4 million$19.2 million
Net income (loss)-$130.8 million-$144.8 million
Cash from operations-$57.6 million$7.5 million
Cash and equivalents$216.9 million$322.4 million

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $70.1 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about MARAVAI LIFESCIENCES HOLDINGS, INC.

What is the ticker symbol of MARAVAI LIFESCIENCES HOLDINGS, INC.?

MARAVAI LIFESCIENCES HOLDINGS, INC. trades under the ticker MRVI on NASDAQ.

Where is MARAVAI LIFESCIENCES HOLDINGS, INC. listed?

MARAVAI LIFESCIENCES HOLDINGS, INC. is listed on NASDAQ.

Which country or territory is MARAVAI LIFESCIENCES HOLDINGS, INC. listed under?

Our directory records MARAVAI LIFESCIENCES HOLDINGS, INC. under United States.

Does aibio.space cover MARAVAI LIFESCIENCES HOLDINGS, INC.?

aibio.space lists MARAVAI LIFESCIENCES HOLDINGS, INC. among 2,820 public biotech companies and publishes its news here as stories appear.

What was MARAVAI LIFESCIENCES HOLDINGS, INC.'s revenue last year?

$185.7 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is MARAVAI LIFESCIENCES HOLDINGS, INC. profitable?

MARAVAI LIFESCIENCES HOLDINGS, INC. reported a net loss of $130.8 million for the fiscal year ended Dec 31, 2025, and used $57.6 million of cash in operations, per its annual report to the SEC.

How much does MARAVAI LIFESCIENCES HOLDINGS, INC. spend on research and development?

$17.4 million in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does MARAVAI LIFESCIENCES HOLDINGS, INC. have?

$70.1 million in cash at Jun 30, 2026, per its 10-Q.

What is the latest MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) stock news?

Our latest story on MARAVAI LIFESCIENCES HOLDINGS, INC., dated Jun 2, 2026: "Maravai LifeSciences signs $150.0 million term loan and $30.0 million revolver". A new credit agreement refinances a 2020 facility, with BSP Agency, LLC as administrative and collateral agent. Source.

Does MARAVAI LIFESCIENCES HOLDINGS, INC. have debt, a term loan or convertible notes?

Our latest debt story, dated Jun 2, 2026: "Maravai LifeSciences signs $150.0 million term loan and $30.0 million revolver". A new credit agreement refinances a 2020 facility, with BSP Agency, LLC as administrative and collateral agent. Source.

How can I follow MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI) news?

Press Follow on this page to add MARAVAI LIFESCIENCES HOLDINGS, INC. to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming MARAVAI LIFESCIENCES HOLDINGS, INC. so far, in Debt Financing.

Investor discussion: MARAVAI LIFESCIENCES HOLDINGS, INC.

Members talk about MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:MRVI on TradingView.

Listing details

MARAVAI LIFESCIENCES HOLDINGS, INC. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker MRVI, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
MARAVAI LIFESCIENCES HOLDINGS, INC.
Ticker
MRVI
Listing
NASDAQ
Country or territory
United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.